---
figid: PMC7864517__ijms-22-01042-g002
figtitle: In the absence of Hedgehog (HH) ligand (SHH, IHH, and DHH), the Patched
  1 (PTCH) transmembrane receptor at the base of the primary cilium maintains inhibition
  of Smoothened (SMO) G protein coupled receptor (GPCR) signaling
organisms:
- Human immunodeficiency virus 1
- Hepatitis B virus
- Human gammaherpesvirus 4
- Influenza A virus
- Human immunodeficiency virus
- Human papillomavirus
- unidentified influenza virus
- Respiratory syncytial virus
- H1N1 subtype
- Human gammaherpesvirus 8
- Human T-cell leukemia virus type I
- DNA viruses
- Enterovirus C
- Merkel cell polyomavirus
- Escherichia coli
- Helicobacter pylori
- Lareunionomyces loeiensis
- Salmonella enterica subsp. enterica serovar Enteritidis
- Macleaya cordata
- Macleaya microcarpa
- Paraechinus aethiopicus
- Erinaceus europaeus
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Danio rerio
- NA
- NA
organisms_ner:
- Erinaceus europaeus
- Mus musculus
- Homo sapiens
- Danio rerio
- Drosophila melanogaster
pmcid: PMC7864517
filename: ijms-22-01042-g002.jpg
figlink: pmc/articles/PMC7864517/figure/ijms-22-01042-f002/
number: F2
caption: In the absence of Hedgehog (HH) ligand (SHH, IHH, and DHH), the Patched 1
  (PTCH) transmembrane receptor at the base of the primary cilium maintains inhibition
  of Smoothened (SMO) G protein coupled receptor (GPCR) signaling. Upon HH binding,
  SMO inhibition is relieved and activates GLI transcription factors, usually sequestered
  by Suppressor of fused (SUFU), KIF7, and FUSED. GLIA refers to the transcriptionally
  active form of GLI. SMO is a popular drug target for cyclopamine, while GLI1 and
  GLI2-induced transcription can be inhibited by GANT61. It inhibits the HH signaling
  pathway downstream of SMO and SUFU, causing GLI1 nuclear accumulation. Target gene
  expression includes CYCLIN D1/2, CYCLIN E1, GLI1, N-MYC, Patched1, VEGF-C, and SNAIL
  to upregulate cell proliferation and tumor survival.
papertitle: 'Hedgehog Signaling: Implications in Cancers and Viral Infections.'
reftext: Sidney Iriana, et al. Int J Mol Sci. 2021 Feb;22(3):1042.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9430871
figid_alias: PMC7864517__F2
figtype: Figure
redirect_from: /figures/PMC7864517__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7864517__ijms-22-01042-g002.html
  '@type': Dataset
  description: In the absence of Hedgehog (HH) ligand (SHH, IHH, and DHH), the Patched
    1 (PTCH) transmembrane receptor at the base of the primary cilium maintains inhibition
    of Smoothened (SMO) G protein coupled receptor (GPCR) signaling. Upon HH binding,
    SMO inhibition is relieved and activates GLI transcription factors, usually sequestered
    by Suppressor of fused (SUFU), KIF7, and FUSED. GLIA refers to the transcriptionally
    active form of GLI. SMO is a popular drug target for cyclopamine, while GLI1 and
    GLI2-induced transcription can be inhibited by GANT61. It inhibits the HH signaling
    pathway downstream of SMO and SUFU, causing GLI1 nuclear accumulation. Target
    gene expression includes CYCLIN D1/2, CYCLIN E1, GLI1, N-MYC, Patched1, VEGF-C,
    and SNAIL to upregulate cell proliferation and tumor survival.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SMO
  - SHH
  - PTCH1
  - KIF7
  - GLI1
  - GLI3
  - GLI2
  - SUFU
  - BCL2
  - VEGFC
  - TWIST2
  - NANOG
  - SOX2
  - Smo
  - Smox
  - Shh
  - H1
  - Ptch1
  - Hand1
  - Nelfcd
  - Kif7
  - Gli1
  - Gli3
  - Gli2
  - Axin1
  - Stk36
  - Sufu
  - Gabrg2
  - Mycn
  - Bcl2
  - Vegfc
  - Snai1
  - Sox2
  - Twist2
  - Nanog
  - SMOX
  - PTCH2
  - AGXT
  - VRK1
  - NELFCD
  - MYCN
  - SNAI1
  - smo
  - shha
  - ptch1
  - ptch2
  - phc1
  - kif7
  - gli1
  - gli3
  - gli2a
  - sufu
  - gli
  - mycn
  - bcl2a
  - vegfc
  - twist2
  - twist3
  - nanog
  - sox2
  - sm
  - ptc
  - Raf
  - TH1
  - cos
  - Su(fu)
  - Gli
  - ci
  - Debcl
  - sna
  - Cyclopamine
  - PTCH1
  - NANOG
---
